CClinicalTrials.gg
CompletedNCT03903874DIALUpdated Apr 21, 2026Results posted

Testing Scalable, IVR-supported Cancer Prevention Interventions in the Rural Alabama Black Belt

An interventional study of Deep south Interactive voice response system supported Active Lifestyle (DIAL) in Physical Activity, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
245
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This protocol involves a randomized controlled trial (N=240) to test the efficacy of the Deep south Active Lifestyle (DIAL intervention) telephone-based physical activity counseling intervention vs. a wait list condition. Assessments of MVPA and psychosocial variables will occur at baseline, 6, 12, and 18 months. Primary aim. Test the efficacy of DIAL intervention vs. wait list control. Hypotheses are that the participants receiving DIAL intervention will report significantly greater increases in MVPA (based on 7-Day Physical Activity Recalls, accelerometers) from baseline to 6 and 12 months than the wait list control arm. Exploratory Aims. Examine 1) Intervention effects on physical performance and psychosocial variables (anxiety, depression, fatigue, sleep disturbance; corroborate self report sleep improvements from pilot with accelerometry); 2) Changes in MVPA from 12-18 months to assess long term (6 months post-intervention) maintenance in the intervention arm and ascertain replicability of intervention effects in wait list control arm; 3) Intervention costs; 4) Potential mediators (social support from family, friends, CHAs, theoretical constructs directly targeted by the intervention) and moderators (education, neighborhood/environmental features) of treatment efficacy; 5) Potential barriers/ facilitators to widespread implementation of DIAL intervention in rural Black belt counties by Deep South Network for Cancer Control.

Read the detailed description

This protocol involves a randomized controlled trial (N=240) to test the efficacy of the Deep south Active Lifestyle (DIAL intervention) telephone-based physical activity counseling intervention vs. a wait list condition. Assessments of MVPA and psychosocial variables will occur at baseline, 6, 12, and 18 months.

Primary aim. Test the efficacy of DIAL intervention vs. wait list control. Hypotheses are that the participants receiving DIAL intervention will report significantly greater increases in MVPA (based on 7-Day Physical Activity Recalls, accelerometers) from baseline to 6 and 12 months than the wait list control arm.

Exploratory Aims. Examine 1) Intervention effects on physical performance and psychosocial variables (anxiety, depression, fatigue, sleep disturbance; corroborate self report sleep improvements from pilot with accelerometry); 2) Changes in MVPA from 12-18 months to assess long term (6 months post-intervention) maintenance in the intervention arm and ascertain replicability of intervention effects in wait list control arm; 3) Intervention costs; 4) Potential mediators (social support from family, friends, CHAs, theoretical constructs directly targeted by the intervention) and moderators (education, neighborhood/environmental features) of treatment efficacy; 5) Potential barriers/ facilitators to widespread implementation of DIAL intervention in rural Black belt counties by Deep South Network for Cancer Control.

02

Conditions studied

  • Physical Activity

Browse trials for

03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 245 is above the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Insufficiently active (engaging in MVPA \< 60 minutes per week)
  • Residents of participating rural Black Belt counties (Dallas, Marengo, Choctaw, Sumter, Hale, Greene)
  • Able to speak and read English
  • Willing to be randomized to either study arm and adhere to study protocol
  • Able to regularly access a telephone (own a cell phone or work/home landline) to complete IVR calls

Exclusion criteria

Exclusion Criteria:

  • Serious medical conditions that would make physical activity unsafe (history of heart disease, myocardial infarction, angina, stroke, orthopedic conditions which limit mobility),
  • Planning to move from the area within the next 18 months.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
245 participants (actual)

Study arms

  • Experimental
    DIAL intervention

    Deep south Interactive voice response system Active Lifestyle (DIAL) intervention. Participants will receive 12 months of automated physical activity phone counseling. Participants will report their physical activity to the IVR system each day for 3 months, twice/week in months 3-6, and once/week in months 6-12 and receive progress feedback via IVR system, along with community health worker support.

    Behavioral: Deep south Interactive voice response system supported Active Lifestyle (DIAL)

  • No intervention
    Wait List Control

    The wait list control participants will be instructed to maintain their normal routine until completion of the 6-month assessments and then receive the same 12-month DIAL intervention. To maintain engagement, these participants will be involved in monthly lunch and learns, focus groups, etc on cancer topics other than PA (e.g., screening) during the wait period.

Interventions

  • BehavioralDeep south Interactive voice response system supported Active Lifestyle (DIAL)

    12 months of automated telephone physical activity counseling with community health worker support

06

What researchers measure

Primary outcomes

  1. Changes in Moderate-vigorous Intensity Physical Activity

    Changes in min/week of moderate-vigorous intensity physical activity from baseline to 6 months, based on 7-Day Physical Activity Recall interviews

    Time frame: baseline, 6 months, 12 months, 18 months

07

Results

Posted Oct 29, 2025

Participant flow

Participant flow — Overall Study
MilestoneDIAL InterventionWait List Control
Started123122
Completed108110
Not completed1512

Outcome measures

PrimaryChanges in Moderate-vigorous Intensity Physical Activity

Changes in min/week of moderate-vigorous intensity physical activity from baseline to 6 months, based on 7-Day Physical Activity Recall interviews

Time frame:
baseline, 6 months, 12 months, 18 months
Reported as:
Least squares mean · min/week of physical activity
Changes in Moderate-vigorous Intensity Physical Activity
min/week of physical activityDIAL InterventionWait List Control
Changes in Moderate-vigorous Intensity Physical Activity67.35 (45.43 to 89.28)4.09 (-17.34 to 25.53)

Adverse events

Collected over 18 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
DIAL Intervention1/123 (0.8%)6/123 (4.9%)10/123 (8.1%)
Wait List Control0/122 (0%)1/122 (0.8%)14/122 (11.5%)
Most frequent serious events
Most frequent serious events
EventDIAL InterventionWait List Control
bursitis, bulging disc; handMusculoskeletal and connective tissue disorders2/1230/122
high blood pressure, triple bypass, strokeCardiac disorders2/1231/122
hospitalizedGeneral disorders1/1230/122
kidney transplantRenal and urinary disorders1/1230/122
Most frequent other events
Most frequent other events
EventDIAL InterventionWait List Control
Back, spine, shoulder, knee, ankle, foot, hipMusculoskeletal and connective tissue disorders10/12314/122

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)DIAL InterventionWait List ControlTotal
<=18 years000
Between 18 and 65 years6973142
>=65 years5449103
Age, Continuous
Age, Continuous(years)DIAL InterventionWait List ControlTotal
Mean59.41 ± 14.2559.27 ± 12.6459.34 ± 13.44
Sex: Female, Male
Sex: Female, Male(Participants)DIAL InterventionWait List ControlTotal
Female113110223
Male101222
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)DIAL InterventionWait List ControlTotal
Hispanic or Latino000
Not Hispanic or Latino123122245
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)DIAL InterventionWait List ControlTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American119120239
White426
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)DIAL InterventionWait List ControlTotal
United States123122245
08

Study locations

1 site
  • University of Alabama At Birmingham
    Birmingham, Alabama 35294, United States
09

References and documents

Publications

  • Brown NI, Powell MA, Baskin M, Oster R, Demark-Wahnefried W, Hardy C, Pisu M, Thirumalai M, Townsend S, Neal WN, Rogers LQ, Pekmezi D. Design and Rationale for the Deep South Interactive Voice Response System-Supported Active Lifestyle Study: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021 May 25;10(5):e29245. doi: 10.2196/29245. PubMed 34032575 ↗

Study documents

  • Protocol and statistical analysis plan · Oct 20, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03903874
Lead sponsor
University of Alabama at Birmingham
Collaborators
National Cancer Institute (NCI)
Responsible party
Dorothy Pekmezi, PhD (Professor, University of Alabama at Birmingham) — Principal investigator
First posted
Apr 4, 2019
Start date
Sep 9, 2020
Primary completion
Nov 26, 2024
Completion
Nov 26, 2024
Results posted
Oct 29, 2025
Last update
Apr 21, 2026

Study contacts

Dorothy Pekmezi, PhD
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion